MicroRNA-218 Inhibits Cell Migration and Invasion in Renal Cell Carcinoma through Targeting Caveolin-2 Involved in Focal Adhesion Pathway

被引:98
作者
Yamasaki, Takeshi [1 ]
Seki, Naohiko [2 ]
Yoshino, Hirofumi [1 ]
Itesako, Toshihiko [1 ]
Hidaka, Hideo [1 ]
Yamada, Yasutoshi [1 ]
Tatarano, Shuichi [1 ]
Yonezawa, Tomokazu [1 ]
Kinoshita, Takashi [2 ]
Nakagawa, Masayuki [1 ]
Enokida, Hideki [1 ]
机构
[1] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima 8908520, Japan
[2] Chiba Univ, Grad Sch Med, Dept Funct Genom, Chiba, Japan
关键词
kidney; carcinoma; renal cell; MIRN218; microRNA; human; caveolin; 2; focal adhesions; BLADDER-CANCER; TUMOR SUPPRESSORS; EXPRESSION; MIR-133A; MIR-218; PHOSPHORYLATION; PROGRESSION; TAGLN2; HEAD;
D O I
10.1016/j.juro.2013.02.089
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Our microRNA expression signature of renal cell carcinoma revealed that miR-218 expression was significantly decreased in cancer tissues, suggesting that miR-218 is a candidate tumor suppressor. We investigated the functional significance of miR-218 in cancer cells and identified what are to our knowledge novel miR-218 mediated cancer pathways in renal cell carcinoma. Materials and Methods: Gain of function studies using mature miR-218 were performed to investigate cell proliferation, migration and invasion in the A498 and 786-O renal cell carcinoma cell lines. To identify miR-218 mediated molecular pathways and responsible genes in renal cell carcinoma, we used gene expression and in silico database analyses. Loss of function assays were performed to investigate the functional significance of miR-218 target genes. Results: Restoration of mature miR-218 significantly inhibited RCC cell proliferation, migration and invasion. Gene expression studies and luciferase reporter assays showed that CAV2 involved in the focal adhesion pathway was directly regulated by miR-218. A silencing study of CAV2 revealed significant inhibition of cell proliferation, migration and invasion. CAV2 mRNA and protein expression was significantly up-regulated in renal cell carcinoma clinical specimens. Conclusions: Loss of tumor suppressive miR-218 enhances cancer cell migration and invasion through dysregulation of the focal adhesion pathway, especially CAV2 as an oncogenic function in renal cell carcinoma. Tumor suppressive microRNA mediated cancer pathways and responsible genes provide new in-sights into the potential mechanisms of renal cell carcinoma oncogenesis and metastasis.
引用
收藏
页码:1059 / 1068
页数:10
相关论文
共 25 条
  • [1] Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae
    Abulrob, A
    Giuseppin, S
    Andrade, MF
    McDermid, A
    Moreno, M
    Stanimirovic, D
    [J]. ONCOGENE, 2004, 23 (41) : 6967 - 6979
  • [2] miR-218 Suppresses Nasopharyngeal Cancer Progression through Downregulation of Survivin and the SLIT2-ROBO1 Pathway
    Alajez, Nehad M.
    Lenarduzzi, Michelle
    Ito, Emma
    Hui, Angela B. Y.
    Shi, Wei
    Bruce, Jeff
    Yue, Shijun
    Huang, Shao H.
    Xu, Wei
    Waldron, John
    O'Sullivan, Brian
    Liu, Fei-Fei
    [J]. CANCER RESEARCH, 2011, 71 (06) : 2381 - 2391
  • [3] Aldred MA, 2003, CANCER RES, V63, P2864
  • [4] miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer
    Chiyomaru, T.
    Enokida, H.
    Tatarano, S.
    Kawahara, K.
    Uchida, Y.
    Nishiyama, K.
    Fujimura, L.
    Kikkawa, N.
    Seki, N.
    Nakagawa, M.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 102 (05) : 883 - 891
  • [5] Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
    Filipowicz, Witold
    Bhattacharyya, Suvendra N.
    Sonenberg, Nahum
    [J]. NATURE REVIEWS GENETICS, 2008, 9 (02) : 102 - 114
  • [6] Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation
    Fong, A
    Garcia, E
    Gwynn, L
    Lisanti, MP
    Fazzari, MJ
    Li, M
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 120 (01) : 93 - 100
  • [7] Gao C, CANCER, V116, P41
  • [8] Caveolin-1 in tumor progression: the good, the bad and the ugly
    Goetz, Jacky G.
    Lajoie, Patrick
    Wiseman, Sam M.
    Nabi, Ivan R.
    [J]. CANCER AND METASTASIS REVIEWS, 2008, 27 (04) : 715 - 735
  • [9] Renal Cell Carcinoma: Focus on Safety and Efficacy of Temsirolimus
    Hadoux, Julien
    Vignot, Stephane
    Rouge, Thibault De La Motte
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2010, 4 : 143 - 154
  • [10] Hidaka H, 2012, ONCOTARGET, V3, P44